RAJESH SINGH: Open Payments
NPI 1710933684 · SIOUX FALLS, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$104,374 in 147 payments from 9 companies in 2025. Trend: 2023 $39,383 · 2024 $121,703 · 2025 $104,374
Speaker / faculty: $74,444Consulting: $18,155Travel & lodging: $9,525Food & beverage: $2,251
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 79 | $67,265 |
| Alkermes, Inc. | 27 | $24,481 |
| Teva Pharmaceuticals USA, Inc. | 13 | $12,161 |
| Otsuka America Pharmaceutical, Inc. | 21 | $326 |
| Vanda Pharmaceuticals Inc. | 1 | $40 |
| Neurocrine BioSciences, Inc. | 2 | $38 |
| Corium, LLC | 2 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
Products named: COBENFY, LYBALVI, UZEDY, AUSTEDO XR, REXULTI, FANAPT, ABILIFY MAINTENA, INGREZZA.
Industry payments across SD — which companies pay providers there.
